LifeStance Health Group, Inc. $LFST Shares Sold by R Squared Ltd

R Squared Ltd lowered its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 16.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,810 shares of the company’s stock after selling 3,240 shares during the period. R Squared Ltd’s holdings in LifeStance Health Group were worth $87,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in LFST. Parcion Private Wealth LLC acquired a new stake in shares of LifeStance Health Group during the 1st quarter worth approximately $15,670,000. Jacobs Levy Equity Management Inc. acquired a new stake in shares of LifeStance Health Group during the 1st quarter worth approximately $7,932,000. Nuveen LLC acquired a new stake in shares of LifeStance Health Group during the 1st quarter worth approximately $6,928,000. Landscape Capital Management L.L.C. acquired a new stake in shares of LifeStance Health Group during the 1st quarter worth approximately $5,135,000. Finally, Vanguard Group Inc. increased its holdings in shares of LifeStance Health Group by 5.0% during the 1st quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company’s stock worth $74,733,000 after buying an additional 531,841 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

Insider Buying and Selling at LifeStance Health Group

In other news, Director Darren M. Black sold 8,407,643 shares of the firm’s stock in a transaction on Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the sale, the director directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of the firm’s stock in a transaction on Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the sale, the insider owned 33,524,715 shares in the company, valued at $169,970,305.05. The trade was a 20.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 20,407,643 shares of company stock valued at $103,466,750 in the last 90 days. Company insiders own 3.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on LFST shares. Wall Street Zen downgraded shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. BTIG Research started coverage on shares of LifeStance Health Group in a research report on Friday, July 25th. They set a “buy” rating and a $8.00 price objective for the company. UBS Group increased their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Zacks Research raised shares of LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of LifeStance Health Group in a research report on Saturday. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Sell rating to the stock. According to MarketBeat, LifeStance Health Group has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

LifeStance Health Group Stock Performance

Shares of LFST stock opened at $5.20 on Monday. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 52 week low of $3.74 and a 52 week high of $8.61. The stock has a market capitalization of $2.02 billion, a PE ratio of -104.00 and a beta of 1.17. The firm has a 50 day moving average of $5.35 and a two-hundred day moving average of $5.37.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The company had revenue of $345.31 million during the quarter, compared to analysts’ expectations of $345.05 million. During the same quarter last year, the company posted ($0.06) EPS. The firm’s revenue was up 10.6% compared to the same quarter last year. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts predict that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.